Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | 8% | 8.2% | 15.1% |
| Success rate | 86% | 68% | 82% |
| Transactions |
5
0% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Corporate Development and Commercial Officer | Ionis Pharmaceuticals Inc | Jan. 9, 2020 - |
| Independent Director | Ardelyx Inc | March 12, 2020 - |
Search